Philipp M Scheiwiller - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Philipp M Scheiwiller

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Journal of Sleep Research|April 26, 2021

Nocturnal cerebral tissue oxygenation in lowlanders with chronic obstructive pulmonary disease travelling to an altitude of 2,590 m: Data from a randomised trialMichael Furian, Deborah Flueck, Philipp M Scheiwiller, et al.

Journal of Clinical Medicine|February 25, 2023

Effect of Acetazolamide on Postural Control in Patients with COPD Travelling to 3100 m Randomized TrialAline Buergin, Michael Furian, Laura Mayer, et al.

Respiration; International Review of Thoracic Diseases|March 5, 2018

Exercise Performance of Lowlanders with COPD at 2,590 m: Data from a Randomized TrialMichael Furian, Sara E Hartmann, Tsogyal D Latshang, et al.

ERJ Open Research|April 9, 2021

Pulmonary haemodynamic response to exercise in highlanders <i>versus</i> lowlandersSilvia Ulrich, Stéphanie Saxer, Michael Furian, et al.

Frontiers in Medicine|March 18, 2021

Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen TherapyMaya Bisang, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

International Journal of Chronic Obstructive Pulmonary Disease|November 23, 2018

Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trialMichael Furian, Deborah Flueck, Tsogyal D Latshang, et al.

Scientific Reports|October 14, 2021

Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trialSophia Gutweniger, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

ERJ Open Research|January 21, 2025

Effects of acetazolamide on exercise performance in patients with COPD going to high altitude: randomised controlled trialRoman F Kind, Michael Furian, Aline Buergin, et al.

The European Respiratory Journal|May 21, 2020

Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 mMona Lichtblau, Stéphanie Saxer, Michael Furian, et al.

JAMA Network Open|June 23, 2020

Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical TrialLu Tan, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

Pageof 2

Search research articles

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Journal of Sleep Research|April 26, 2021

Nocturnal cerebral tissue oxygenation in lowlanders with chronic obstructive pulmonary disease travelling to an altitude of 2,590 m: Data from a randomised trialMichael Furian, Deborah Flueck, Philipp M Scheiwiller, et al.

Journal of Clinical Medicine|February 25, 2023

Effect of Acetazolamide on Postural Control in Patients with COPD Travelling to 3100 m Randomized TrialAline Buergin, Michael Furian, Laura Mayer, et al.

Respiration; International Review of Thoracic Diseases|March 5, 2018

Exercise Performance of Lowlanders with COPD at 2,590 m: Data from a Randomized TrialMichael Furian, Sara E Hartmann, Tsogyal D Latshang, et al.

ERJ Open Research|April 9, 2021

Pulmonary haemodynamic response to exercise in highlanders <i>versus</i> lowlandersSilvia Ulrich, Stéphanie Saxer, Michael Furian, et al.

Frontiers in Medicine|March 18, 2021

Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen TherapyMaya Bisang, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

International Journal of Chronic Obstructive Pulmonary Disease|November 23, 2018

Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trialMichael Furian, Deborah Flueck, Tsogyal D Latshang, et al.

Scientific Reports|October 14, 2021

Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trialSophia Gutweniger, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

ERJ Open Research|January 21, 2025

Effects of acetazolamide on exercise performance in patients with COPD going to high altitude: randomised controlled trialRoman F Kind, Michael Furian, Aline Buergin, et al.

The European Respiratory Journal|May 21, 2020

Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 mMona Lichtblau, Stéphanie Saxer, Michael Furian, et al.

JAMA Network Open|June 23, 2020

Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical TrialLu Tan, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.

Pageof 2